The aim of this work is to map out the risks associated with the use of aesthetic mesotherapy (AM) in France. The work has thus attempted to document the following types of risks:
- infectious risks;
- pharmacological risks;
- those associated with certain psychopathological settings.
The analysis took account of additional aims that put the risk mapping and mesotherapy itself into context
See also
HAS opinions and decisions
22/07/2014
Health technology assessment
08/04/2011
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
kaYVCK17r45e91GY